← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Geneventiv Therapeutics, Inc.
Raleigh, NC
$2,542,236
Total funding
1
Grants
Funding over time
peak $1.3M · FY2024–25$2M$1.5M$1M$500K$0
'24
'25
Funding mix
By agency
NIH$2,542,236 · 1
By mechanism
R44$2,542,236 · 1
Investigators at Geneventiv Therapeutics, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Development of a universal gene therapy for hemophilia A or B with or without inhibitors$1,266,694
R44 · FY2025 · HL
Development of a universal gene therapy for hemophilia A or B with or without inhibitors$1,230,198
R44 · FY2024 · HL
Development of a universal gene therapy for hemophilia A or B with or without inhibitors$45,344
R44 · FY2025 · HL